[
  {
    "ts": null,
    "headline": "All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year",
    "summary": "Income-focused investors seeking reliable dividends and a stable company can consider investing in telecommunications giant Verizon.  AT&T’s disciplined financial management is supporting its solid 4.1% dividend yield.  AbbVie’s ability to thrive post-Humira, combined with a 53-year history of dividend growth, makes it a smart buy now.",
    "url": "https://finnhub.io/api/news?id=e24b681ca9267f0487856afbfe098dee961fa63a5ce0245308c97d1086a1fccf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752920100,
      "headline": "All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year",
      "id": 136019741,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Income-focused investors seeking reliable dividends and a stable company can consider investing in telecommunications giant Verizon.  AT&T’s disciplined financial management is supporting its solid 4.1% dividend yield.  AbbVie’s ability to thrive post-Humira, combined with a 53-year history of dividend growth, makes it a smart buy now.",
      "url": "https://finnhub.io/api/news?id=e24b681ca9267f0487856afbfe098dee961fa63a5ce0245308c97d1086a1fccf"
    }
  },
  {
    "ts": null,
    "headline": "Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector",
    "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AbbVie Inc. (NYSE:ABBV) stands out as a major player in the pharmaceutical industry, with a broad range of approved treatments. Among its most significant offerings are the immunology drugs Skyrizi and Rinvoq, which are expected to contribute to revenue growth […]",
    "url": "https://finnhub.io/api/news?id=9162f6f1c3067a9dee7149ea4316d163c4b7de7d2bdeacaa97b689bf1aec9b11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752888909,
      "headline": "Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector",
      "id": 136011821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AbbVie Inc. (NYSE:ABBV) stands out as a major player in the pharmaceutical industry, with a broad range of approved treatments. Among its most significant offerings are the immunology drugs Skyrizi and Rinvoq, which are expected to contribute to revenue growth […]",
      "url": "https://finnhub.io/api/news?id=9162f6f1c3067a9dee7149ea4316d163c4b7de7d2bdeacaa97b689bf1aec9b11"
    }
  }
]